Question 31 All are true about Tocilizumab except: ATocilizumab is a humanized monoclonal antibody directed against the membrane and soluble forms of the IL-6 receptor. BIt has been shown to decrease LDL cholesterol. CTocilizumab has been associated with an increased risk of infection, neutropenia, and Thrombocytopenia. DThe hematologic abnormalities appear to be reversible upon stopping the drug. ← PreviousNext →
